Status:
COMPLETED
Modified Adaptive Servoventilation (ASV) Compared to Conventional ASV
Lead Sponsor:
ResMed
Conditions:
Periodic Breathing
Breathing-Related Sleep Disorder
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
This study will determine if modified adaptive servoventilation (ASV) is as effective as the conventional ASV in treating periodic breathing. The study will determine if the modified ASV reacts approp...
Detailed Description
Adaptive servoventilation (ASV) is a type of non-invasive ventilation which ameliorates central sleep and/or mixed apnea and periodic breathing. Previous studies in the field have shown that treatment...
Eligibility Criteria
Inclusion
- 21+ years old
- Chronic ResMed ASV therapy patient
- Current ASV therapy for at least 4 weeks
- Able to understand fully the study information and participation requirements
- Provide signed informed consent
Exclusion
- Acute cardiac decompensation
- Acute myocardial infarction within last 3 months
- Resuscitation within last 3 months
- Stroke with swallowing disorders or persistent hemiparesis
- Blood pressure test at end expiratory pressure (EEP) 10cmH2O not passed
- Untreated restless legs syndrome
- Alcohol or drug abuse
- Known cancer
- Pregnancy
- Conditions that could interfere with patients participating in and completing the protocol and/or the investigator deems their enrolment unsuitable
Key Trial Info
Start Date :
July 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2011
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT01405313
Start Date
July 1 2011
End Date
September 1 2011
Last Update
March 20 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Heart and Diabetes Centre, Ruhr University Bochum
Bad Oeynhausen, North Rhine-Westphalia, Germany, D-32545